Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction

W. Mazur, T. Toljamo, P. Nieminen, S. Ohlmeier, H. Kobayashi, V. Kinnula (Rovaniemi, Oulu, Finland; Tokorozawa, Japan)

Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Session: COPD: phenotyping and monitoring
Session type: Thematic Poster Session
Number: 1313
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Mazur, T. Toljamo, P. Nieminen, S. Ohlmeier, H. Kobayashi, V. Kinnula (Rovaniemi, Oulu, Finland; Tokorozawa, Japan). Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction. Eur Respir J 2010; 36: Suppl. 54, 1313

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Plasma leakage is elevated in COPD airways
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005

Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 584s
Year: 2005

Elevated BALF PEDF levels are related to disease severity, inflammation and small airway obstruction in COPD patientes
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Elevated hsCRP is associated with respiratory symptoms in COPD
Source: International Congress 2019 – More and more COPD
Year: 2019

Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018



Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma
Source: Eur Respir J 2014; 44: 895-904
Year: 2014



Correlation between serum levels of infiammatory markers and airflow obstruction
Source: Eur Respir J 2004; 24: Suppl. 48, 352s
Year: 2004

Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis
Source: Eur Respir J 2015; 46: 1501-1503
Year: 2015


Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001

Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum
Source: Eur Respir J 2002; 20: Suppl. 38, 143s
Year: 2002

Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


High IL-8 levels correlating with a neutrophilic airway inflammation in children with respiratory symptoms and gastroesophageal reflux (GER)
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002

Spontaneous airway obstruction masks FeNO level in patients with asthma but not COPD
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

Serum levels of IL-8 is related to airflow limitation in mild and severe asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 548s
Year: 2003

Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Airway FABP4 is decreased in COPD patients with airway bacterial infection
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Plasma eotaxin level in children with acute bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 314s
Year: 2003

Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

Increased levels of hyaluronan in induced sputum from COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003